| Trial ID: | L6975 |
| Source ID: | NCT01510093
|
| Associated Drug: |
Insulin Aspart 100 Ie/Ml
|
| Title: |
Diurnal Variation of Exogenous Peptides (Endogenous Insulin Jurgita II)
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Insulin Aspart 100 IE/ml
|
| Outcome Measures: |
Primary: Pharmacokinetic profiles of endogenous insulin and Insulin Aspart, Pharmacokinetic profiles of endogenous insulin and Insulin Aspart in type 2 diabetes melitus patients treated with continuous subcutaneous Insulin Aspart infusion by insulin pump and combined with or without intravenous supply of glucose, 10 hours | Secondary: Pharmacodynamic glucose profiles, Pharmacodynamic glucose profiles after treatment with Insulin Aspart administred by insulin pump as a continuous subcutaneous infusion ., 10 hours
|
| Sponsor/Collaborators: |
Sponsor: Aarhus University Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
10
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2012-05
|
| Completion Date: |
2013-01
|
| Results First Posted: |
|
| Last Update Posted: |
2013-01-29
|
| Locations: |
Department of Endocrinology and Internal Diseases, Aarhus C, Central Denmark Region, 8000, Denmark
|
| URL: |
https://clinicaltrials.gov/show/NCT01510093
|
